vildagliptin/metforminhydrochlorid "zentiva" 50+850 mg filmovertrukne tabletter
zentiva k.s. - metforminhydrochlorid, vildagliptin - filmovertrukne tabletter - 50+850 mg
vildagliptin/metforminhydrochlorid "zentiva" 50+1000 mg filmovertrukne tabletter
zentiva k.s. - metforminhydrochlorid, vildagliptin - filmovertrukne tabletter - 50+1000 mg
vildagliptin/metformin "krka" 50+850 mg filmovertrukne tabletter
krka d.d. novo mesto - metforminhydrochlorid, vildagliptin - filmovertrukne tabletter - 50+850 mg
vildagliptin/metformin "teva" 50+850 mg filmovertrukne tabletter
teva b.v. - metforminhydrochlorid, vildagliptin - filmovertrukne tabletter - 50+850 mg
vildagliptin/metformin "sandoz" 50+850 mg filmovertrukne tabletter
sandoz a/s - metforminhydrochlorid, vildagliptin - filmovertrukne tabletter - 50+850 mg
vildagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, type 2 - narkotika anvendt i diabetes - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgængelige data på forskellige kombinationer).
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptin, metformin-hydrochlorid - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgængelige data på forskellige kombinationer).
vildagliptin/metformin "teva" 50+1000 mg filmovertrukne tabletter
teva b.v. - metforminhydrochlorid, vildagliptin - filmovertrukne tabletter - 50+1000 mg
vildagliptin/metformin "krka" 50+1000 mg filmovertrukne tabletter
krka d.d. novo mesto - metforminhydrochlorid, vildagliptin - filmovertrukne tabletter - 50+1000 mg
vildagliptin/metformin "sandoz" 50+1000 mg filmovertrukne tabletter
sandoz a/s - metforminhydrochlorid, vildagliptin - filmovertrukne tabletter - 50+1000 mg